Sandbox: Peripheral Arterial Disease: Difference between revisions
Jump to navigation
Jump to search
Arzu Kalayci (talk | contribs) |
Arzu Kalayci (talk | contribs) |
||
| Line 10: | Line 10: | ||
! style="width:50%" | '''2011''' | ! style="width:50%" | '''2011''' | ||
! style="width:50%" | '''2017''' | ! style="width:50%" | '''2017''' | ||
|- | |||
| colspan="2" | {{Fontcolor|#FF0000|2017 Change in Recommendations:}} | |||
|- | |- | ||
| colspan="2" | '''Carotid Artery Disease''' | | colspan="2" | '''Carotid Artery Disease''' | ||
|- | |- | ||
| bgcolor="LemonChiffon" | IIb - Embolic Protection Devices (EPDs)in Carotid Stenting || bgcolor="LemonChiffon" | IIa - Embolic Protection Devices (EPDs)in Carotid Stenting | | bgcolor="LemonChiffon" | IIb - Embolic Protection Devices (EPDs)in Carotid Stenting || bgcolor="LemonChiffon" | IIa - Embolic Protection Devices (EPDs)in Carotid Stenting | ||
| Line 30: | Line 30: | ||
|- | |- | ||
| colspan="2" bgcolor="LightCoral" | III - Routine prophylactic revascularization of asymptomatic carotid 70-99% stenosis in patients undergoing CABG. | | colspan="2" bgcolor="LightCoral" | III - Routine prophylactic revascularization of asymptomatic carotid 70-99% stenosis in patients undergoing CABG. | ||
|- | |||
| colspan="2" | {{Fontcolor|#FF0000|2017 Change in Recommendations:}} | |||
|- | |- | ||
| colspan="2" | '''Upper Extremity Artery Disease''' | | colspan="2" | '''Upper Extremity Artery Disease''' | ||
|- | |- | ||
| bgcolor="LightGreen" | I - Revascularisation for symptomatic subclavian artery stenosis || bgcolor="LemonChiffon" | IIa - Revascularisation for symptomatic subclavian artery stenosis | | bgcolor="LightGreen" | I - Revascularisation for symptomatic subclavian artery stenosis || bgcolor="LemonChiffon" | IIa - Revascularisation for symptomatic subclavian artery stenosis | ||
Revision as of 13:34, 30 October 2017
==2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases (PAD), in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)==
Changes in Recommendations
What is new in the 2017 PAD Guidelines
| 2011 | 2017 |
|---|---|
| 2017 Change in Recommendations: | |
| Carotid Artery Disease | |
| IIb - Embolic Protection Devices (EPDs)in Carotid Stenting | IIa - Embolic Protection Devices (EPDs)in Carotid Stenting |
| Asymptomatic 60-90% carotid stenosis | |
| IIa - Surgery for all | IIa - Surgery for high stroke risk |
| IIb - Stenting as an alternative | IIa - Stenting in high surgery risk |
| IIa - Stenting in average surgery risk | |
| 2017 New Recommendations: | |
| IIb - Coronary angiography before elective carotid surgery | |
| III - Routine prophylactic revascularization of asymptomatic carotid 70-99% stenosis in patients undergoing CABG. | |
| 2017 Change in Recommendations: | |
| Upper Extremity Artery Disease | |
| I - Revascularisation for symptomatic subclavian artery stenosis | IIa - Revascularisation for symptomatic subclavian artery stenosis |
| Subclavian stenosis revascularization | |
| I - Endovascular first | IIa - Stenting or surgery |
| IIb - Revascularization for asymptomatic subclavian stenosis in patients with/planned for CABG | IIa - Revascularization for asymptomatic subclavian stenosis in patients with/planned for CABG |